4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-057382
Chief Scientific Officer sold 33,300 shares at an average $50.70 ($1,688,247)
- Chief Scientific Officer acquired 33,300 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
ROBINS HARLAN S · Chief Scientific Officer
Table I: Non-derivative
10 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-11-04 | Exercise or conversion : show line 1 in the form | +11,100 | $6.32 | $70,152 | 11,779 | D |
| 2020-11-04 | Sale : show line 2 in the form | −9,800 | $50.20 | $491,960 | 1,979 | D |
| 2020-11-04 | Sale : show line 3 in the form | −1,300 | $50.98 | $66,274 | 679 | D |
| 2020-11-05 | Exercise or conversion : show line 4 in the form | +11,100 | $6.32 | $70,152 | 11,779 | D |
| 2020-11-05 | Sale : show line 5 in the form | −7,254 | $50.00 | $362,700 | 4,525 | D |
| 2020-11-05 | Sale : show line 6 in the form | −3,846 | $50.88 | $195,684 | 679 | D |
| 2020-11-06 | Exercise or conversion : show line 7 in the form | +11,100 | $6.32 | $70,152 | 11,779 | D |
| 2020-11-06 | Sale : show line 8 in the form | −1,500 | $50.48 | $75,720 | 10,279 | D |
| 2020-11-06 | Sale : show line 9 in the form | −8,700 | $51.57 | $448,659 | 1,579 | D |
| 2020-11-06 | Sale : show line 10 in the form | −900 | $52.50 | $47,250 | 679 | D |
| Open-market sales · 33,300 sh · avg $50.70 · $1,688,247 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-11-04 | Exercise or conversion : show line 11 in the form Stock Option (Right to Buy) | −11,100 | 255,900 | D |
| 2020-11-05 | Exercise or conversion : show line 12 in the form Stock Option (Right to Buy) | −11,100 | 244,800 | D |
| 2020-11-06 | Exercise or conversion : show line 13 in the form Stock Option (Right to Buy) | −11,100 | 233,700 | D |
Loading xslF345X03/doc4.xml…